Tearsheet

US Physical Therapy (USPH)


Market Price (1/22/2026): $87.55 | Market Cap: $1.3 Bil
Sector: Health Care | Industry: Health Care Facilities

US Physical Therapy (USPH)


Market Price (1/22/2026): $87.55
Market Cap: $1.3 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.


0 Low stock price volatility
Vol 12M is 36%
Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -70%
Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 40x
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more.
  Key risks
USPH key risks include [1] significant profitability pressure from government payor rate cuts and [2] challenges in executing its growth strategy, Show more.
0 Low stock price volatility
Vol 12M is 36%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more.
2 Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -70%
3 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 40x
4 Key risks
USPH key risks include [1] significant profitability pressure from government payor rate cuts and [2] challenges in executing its growth strategy, Show more.

Valuation, Metrics & Events

USPH Stock


Why The Stock Moved


Qualitative Assessment

AI Analysis | Feedback

US Physical Therapy (USPH) stock has remained largely at the same level since 9/30/2025 because of the following key factors:

1. Steady Q3 2025 Financial Performance Largely Met Expectations. U.S. Physical Therapy reported strong third-quarter 2025 results, with total net revenue up 17.8% to $168.1 million and Adjusted EBITDA increasing by 13.2% year-over-year to $23.9 million. Physical therapy operations saw an 18.0% rise in visits, and the company reaffirmed its full-year 2025 Adjusted EBITDA guidance of $93.0 million to $97.0 million. However, the reported diluted EPS of $0.48, or $0.66, generally met analysts' expectations, or slightly missed by $0.01 depending on the source. This suggests that while operational performance was solid, it was largely anticipated by the market and therefore did not trigger a significant upward revision in the stock price.

2. Consistent Analyst Sentiment and Price Targets. Throughout the period, Wall Street analysts maintained a "Moderate Buy" or "Buy" consensus rating for USPH, with an average twelve-month price target ranging from $105.33 to $106.50. These targets implied a notable upside from the stock's prevailing price (e.g., 22.58% from $85.93). The consistency in ratings and price targets indicates a stable, albeit not explosively bullish, outlook. The absence of significant upgrades or downgrades suggests that the company's trajectory and valuation were considered generally fair, contributing to the stock's relatively stable trading range.

Show more

Stock Movement Drivers

Fundamental Drivers

The 0.3% change in USPH stock from 10/31/2025 to 1/21/2026 was primarily driven by a 4.0% change in the company's Total Revenues ($ Mil).
103120251212026Change
Stock Price ($)85.7386.010.3%
Change Contribution ByLTMLTM 
Total Revenues ($ Mil)7307594.0%
Net Income Margin (%)4.6%4.4%-4.7%
P/E Multiple39.139.61.3%
Shares Outstanding (Mil)15150.0%
Cumulative Contribution0.3%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 1/21/2026
ReturnCorrelation
USPH0.3% 
Market (SPY)0.5%39.0%
Sector (XLV)9.7%12.8%

Fundamental Drivers

The 19.0% change in USPH stock from 7/31/2025 to 1/21/2026 was primarily driven by a 18.1% change in the company's P/E Multiple.
73120251212026Change
Stock Price ($)72.3086.0119.0%
Change Contribution ByLTMLTM 
Total Revenues ($ Mil)6997598.5%
Net Income Margin (%)4.7%4.4%-6.7%
P/E Multiple33.539.618.1%
Shares Outstanding (Mil)1515-0.5%
Cumulative Contribution19.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 1/21/2026
ReturnCorrelation
USPH19.0% 
Market (SPY)8.7%30.4%
Sector (XLV)21.9%10.2%

Fundamental Drivers

The -0.7% change in USPH stock from 1/31/2025 to 1/21/2026 was primarily driven by a -66.4% change in the company's P/E Multiple.
13120251212026Change
Stock Price ($)86.6586.01-0.7%
Change Contribution ByLTMLTM 
Total Revenues ($ Mil)64675917.5%
Net Income Margin (%)1.7%4.4%153.4%
P/E Multiple117.739.6-66.4%
Shares Outstanding (Mil)1515-0.8%
Cumulative Contribution-0.7%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2025 to 1/21/2026
ReturnCorrelation
USPH-0.7% 
Market (SPY)14.9%43.1%
Sector (XLV)9.2%29.0%

Fundamental Drivers

The -7.9% change in USPH stock from 1/31/2023 to 1/21/2026 was primarily driven by a -38.7% change in the company's Net Income Margin (%).
13120231212026Change
Stock Price ($)93.4186.01-7.9%
Change Contribution ByLTMLTM 
Total Revenues ($ Mil)54275940.0%
Net Income Margin (%)7.1%4.4%-38.7%
P/E Multiple31.539.625.5%
Shares Outstanding (Mil)1315-16.9%
Cumulative Contribution-10.6%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2023 to 1/21/2026
ReturnCorrelation
USPH-7.9% 
Market (SPY)74.9%42.9%
Sector (XLV)24.2%32.6%

Return vs. Risk


Price Returns Compared

 202120222023202420252026Total [1]
Returns
USPH Return-19%-14%17%-3%-10%9%-22%
Peers Return-26%-38%1%26%1%8%-37%
S&P 500 Return27%-19%24%23%16%-1%81%

Monthly Win Rates [3]
USPH Win Rate42%50%50%42%50%100% 
Peers Win Rate38%35%39%52%50%100% 
S&P 500 Win Rate75%42%67%75%67%0% 

Max Drawdowns [4]
USPH Max Drawdown-29%-21%-1%-16%-26%0% 
Peers Max Drawdown-37%-46%-21%-12%-19%-1% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: SEM, CON, EHAB, PNTG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 1/21/2026 (YTD)

How Low Can It Go

Unique KeyEventUSPHS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-47.4%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven90.0%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-64.2%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven179.3%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven314 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-27.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven37.1%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven178 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-64.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven183.6%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven657 days1,480 days

Compare to SEM, CON, EHAB, PNTG

In The Past

US Physical Therapy's stock fell -47.4% during the 2022 Inflation Shock from a high on 2/24/2021. A -47.4% loss requires a 90.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About US Physical Therapy (USPH)

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe US Physical Therapy (USPH) succinctly:

  • The Starbucks of physical therapy clinics.

  • The Aspen Dental for physical therapy.

  • The CVS MinuteClinic model for physical therapy.

AI Analysis | Feedback

  • Physical Therapy Services: Direct patient care focused on rehabilitation for musculoskeletal, neurological, and post-operative conditions, aiming to restore movement and function.
  • Occupational Therapy Services: Direct patient care aimed at helping patients improve their ability to perform daily living and work activities through therapeutic interventions.
  • Outpatient Clinic Management Services: Provides administrative, billing, marketing, and operational support to its network of affiliated physical and occupational therapy clinics.

AI Analysis | Feedback

US Physical Therapy (USPH) primarily sells its services directly to individuals.

The up to three categories of customers that it serves are:

  1. Patients recovering from acute injuries or surgeries: This category includes individuals who have experienced sports injuries, work-related accidents, motor vehicle accidents, or are undergoing post-operative rehabilitation (e.g., after joint replacement, spinal surgery, or other orthopedic procedures).
  2. Individuals managing chronic conditions or age-related functional decline: This segment comprises patients with chronic pain (such as back pain, neck pain, or fibromyalgia), arthritis, neurological disorders (e.g., stroke, Parkinson's disease, multiple sclerosis), or those experiencing age-related balance issues and decreased mobility.
  3. Athletes and active individuals seeking performance enhancement or injury prevention: This category includes individuals looking to improve athletic performance, prevent future injuries, enhance flexibility and strength, or safely return to sports and activities after a period of inactivity or minor issue.

AI Analysis | Feedback

null

AI Analysis | Feedback

Christopher J. Reading, Chief Executive Officer and Chairman of the Board of Directors

Mr. Reading has served as Chief Executive Officer and a Director of U.S. Physical Therapy since 2004, and was appointed Chairman of the Board of Directors in May 2024. He previously held the position of President. From 1990 to 2003, Mr. Reading served in various executive and management positions with HealthSouth Corporation, where his last role was Senior Vice President of Operations, responsible for over 200 facilities across 10 states. He started his career as a clinician, graduating with a B.S. in Physical Therapy from the Medical College of Virginia in 1985. Mr. Reading also serves as President of APTQI (Alliance for Physical Therapy, Quality and Innovation).

Carey P. Hendrickson, Chief Financial Officer

Mr. Hendrickson joined U.S. Physical Therapy as Chief Financial Officer in November 2020. Prior to this, he served as Chief Financial Officer at Capital Senior Living Corporation from May 2014 to November 2020. From 2010 through 2014, he was Senior Vice President/Chief Financial Officer and Treasurer of Belo Corp., a television company. He also held various other roles at Belo Corp., including Senior Vice President/Chief Accounting Officer, Vice President/Human Resources, Vice President/Investor Relations and Corporate Communications, and Vice President/Strategic & Financial Planning. Mr. Hendrickson began his career with KPMG LLP and was the director of financial planning for Republic Financial Services before joining Belo in 1992. He holds a BBA in accounting from Baylor University and an MBA from the University of Texas at Arlington.

Eric Williams, President and Chief Operating Officer

Mr. Williams was appointed President and Chief Operating Officer in May 2024. He previously served as Chief Operating Officer for the eastern region of U.S. Physical Therapy from 2021 to 2024. Before joining USPH, he served as President and Chief Operating Officer for Omni Ophthalmic Management Consultants, and prior to that, he was Chief Operating Officer and then Chief Executive Officer of Drayer Physical Therapy Institute, LLC.

Graham Reeve, Chief Operating Officer

Mr. Reeve serves as a Chief Operating Officer for U.S. Physical Therapy.

Rick Binstein, Executive Vice President and General Counsel

Mr. Binstein holds the position of Executive Vice President and General Counsel at U.S. Physical Therapy.

AI Analysis | Feedback

The key risks to US Physical Therapy (USPH) are:

  1. Reimbursement Pressure from Government Payors: US Physical Therapy faces significant and ongoing pressure from government payors, particularly Medicare, which directly impacts its net revenue per patient visit and overall profitability. Analysts have flagged this as a primary external risk and a constant regulatory headwind. Cumulative rate cuts have reportedly cost USPH millions in annual profits. While the company has implemented strategies to mitigate these cuts, such as boosting commercial and workers' compensation business and driving patient volume, future adjustments to Medicare's payment formula remain a substantial risk.
  2. Availability and Cost of Qualified Physical Therapists: The business operations of US Physical Therapy are highly dependent on its ability to hire, train, and retain qualified physical therapists. The availability and cost of these professionals represent a continuous operational challenge that can affect staffing levels, service delivery, and overall operating expenses.
  3. Integration Risk with Acquisitions and Competition in Industrial Injury Prevention: A key component of USPH's growth strategy involves strategic acquisitions. However, these acquisitions carry an inherent risk of integration failure. Furthermore, the company's industrial injury prevention services segment operates in a competitive environment, which could lead to the termination or non-renewal of contractual service arrangements and adverse financial consequences for that business line.

AI Analysis | Feedback

  • Rise of Digital Musculoskeletal (MSK) Care Platforms: Companies such as Hinge Health, SWORD Health, and Kaia Health are rapidly expanding, offering virtual and app-based physical therapy programs directly to employers and health plans. These platforms provide a convenient, often lower-cost alternative to traditional in-clinic physical therapy, potentially diverting a significant patient population, particularly for non-acute or chronic conditions, and challenging USPH's core clinic-based business model.
  • Acute Shortages and Wage Inflation for Physical Therapists: The physical therapy industry is experiencing escalating shortages of qualified physical therapists and physical therapist assistants. This tight labor market drives up staffing costs and wages, USPH's largest operating expense, and creates significant challenges in recruiting and retaining staff, opening new clinics, and maintaining optimal service capacity. This trend threatens profit margins and limits growth potential.

AI Analysis | Feedback

The addressable market for U.S. Physical Therapy's main products or services in the U.S. is as follows:

  • Outpatient Physical and Occupational Therapy Services: The U.S. occupational and physical therapy services market was valued at approximately USD 59.43 billion in 2024. This market is projected to grow to USD 128.17 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2025 to 2032. Another estimate places the U.S. physical therapy services market size at USD 47.59 billion in 2024, with an expected increase to USD 61.70 billion by 2030, growing at a CAGR of 4.60% from 2025 to 2030.
  • Industrial Injury Prevention Services: null

AI Analysis | Feedback

US Physical Therapy (USPH) is expected to drive future revenue growth over the next two to three years through a combination of strategic initiatives aimed at expanding its footprint, optimizing reimbursement, growing specialized services, increasing patient volumes, and leveraging technology.

  1. Clinic Expansion through Acquisitions and De Novo Development: USPH consistently expands its network by acquiring existing practices and opening new "de novo" clinics. In the third quarter of 2025 alone, the company added 18 new clinics, bringing its total to 779, and reported 84 net owned clinic additions since the third quarter of 2024. This ongoing expansion directly contributes to increased patient access and overall revenue.
  2. Increased Net Rate Per Patient Visit and Payer Rate Initiatives: The company has demonstrated success in enhancing its net rate per patient visit. This is achieved through favorable contract negotiations with commercial and other third-party payors, as well as an increasing proportion of higher-reimbursing workers' compensation cases in its revenue mix. Management also anticipates potential improvements in Medicare pricing in 2026, which would further boost rates. For example, the net rate per patient visit reached $105.54 in Q3 2025.
  3. Growth in Industrial Injury Prevention (IIP) Services: USPH's Industrial Injury Prevention segment is a significant and consistently growing revenue stream. This segment focuses on providing services to employers for workplace injury prevention and treatment. The IIP net revenues increased by 14.6% year-over-year in Q3 2025, and this growth is often organic. In Q4 2024, IIP revenues saw an impressive 32.1% increase over the prior year.
  4. Increased Patient Volume and Visits per Clinic: The company has experienced strong patient demand, leading to higher overall patient visits and a record average number of visits per clinic per day. In Q3 2025, total patient visits increased by 18% year-over-year, supported by a 2.2% increase in visits at mature clinics and hitting a record-high average of 32.2 daily patient visits per clinic. This sustained increase in patient traffic across its clinics is a fundamental driver of revenue growth.
  5. Technology-Driven Efficiency and Enhanced Patient Experience: USPH is investing in technology, such as AI-powered tools for clinical documentation and a "semi-virtualized" front desk model, to streamline operations and reduce administrative burdens. While these initiatives primarily aim to mitigate labor shortages and manage costs, they also enhance patient retention and throughput, allowing clinics to serve more patients efficiently and contribute to incremental revenue, including through new cash-based programs.

AI Analysis | Feedback

Share Repurchases

  • The Board of Directors authorized a share repurchase program for up to $25 million through December 31, 2026, as announced during the Q3 2025 earnings call.

Share Issuance

  • Operating results per share in 2024 were impacted by an increase in the number of shares outstanding, largely due to a secondary offering completed in May 2023.
  • As of November 7, 2025, the number of shares outstanding (issued less treasury stock) was 15,204,119.

Outbound Investments

  • Acquisitions remain US Physical Therapy's primary capital allocation priority, consistent with its strategic growth strategy.
  • In 2024, the company added 103 clinics and acquired a 75% equity interest in a three-clinic practice with $6.5 million in annual revenues.
  • During the first three quarters of 2025, significant acquisitions included a 65% equity interest in a three-clinic practice generating $4.3 million in annual revenue, a 60% equity interest in another three-clinic practice generating $5.3 million in annual revenue, and an outpatient home care physical and speech therapy practice through its 50%-owned subsidiary.

Capital Expenditures

  • The company's capital expenditures primarily focus on the expansion of its clinic network through the addition of new clinics and acquisitions.
  • USPH added a net of 84 owned clinics since the comparable prior year period, contributing to increased physical therapy operations.
  • Specific dollar values for total capital expenditures were not explicitly detailed as a distinct line item within the provided summaries; however, investment in new clinics and acquisitions drives capital deployment.

Better Bets than US Physical Therapy (USPH)

Trade Ideas

Select ideas related to USPH. For more, see Trefis Trade Ideas.

Unique Key

Recent Active Movers

More From Trefis

Peer Comparisons for US Physical Therapy

Peers to compare with:

Financials

USPHSEMCONEHABPNTGMedian
NameUS Physi.Select M.Concentr.Enhabit Pennant  
Mkt Price86.0115.3321.9910.7430.0021.99
Mkt Cap1.31.82.80.51.01.3
Rev LTM7595,3692,0891,0488471,048
Op Inc LTM75293323624375
FCF LTM57174176583658
FCF 3Y Avg65239-522259
CFO LTM70408254624870
CFO 3Y Avg75465-573266

Growth & Margins

USPHSEMCONEHABPNTGMedian
NameUS Physi.Select M.Concentr.Enhabit Pennant  
Rev Chg LTM17.5%45.3%11.4%1.0%29.9%17.5%
Rev Chg 3Y Avg11.9%-0.6%--1.1%22.7%5.7%
Rev Chg Q17.3%7.2%17.0%3.9%26.8%17.0%
QoQ Delta Rev Chg LTM4.0%1.7%4.1%1.0%6.1%4.0%
Op Mgn LTM9.9%5.5%15.5%5.9%5.0%5.9%
Op Mgn 3Y Avg10.6%4.3%-4.8%5.0%4.9%
QoQ Delta Op Mgn LTM0.2%0.2%-0.2%0.6%-0.4%0.2%
CFO/Rev LTM9.2%7.6%12.2%5.9%5.7%7.6%
CFO/Rev 3Y Avg11.4%10.5%-5.4%4.6%8.0%
FCF/Rev LTM7.5%3.2%8.4%5.5%4.3%5.5%
FCF/Rev 3Y Avg9.9%5.6%-5.0%3.2%5.3%

Valuation

USPHSEMCONEHABPNTGMedian
NameUS Physi.Select M.Concentr.Enhabit Pennant  
Mkt Cap1.31.82.80.51.01.3
P/S1.70.31.30.51.21.2
P/EBIT14.55.78.719.923.614.5
P/E39.616.818.4-45.838.918.4
P/CFO18.84.511.18.821.711.1
Total Yield3.6%8.1%6.0%-2.2%2.6%3.6%
Dividend Yield1.0%2.2%0.6%0.0%0.0%0.6%
FCF Yield 3Y Avg5.0%10.4%-11.7%3.1%7.7%
D/E0.21.50.80.90.30.8
Net D/E0.21.50.70.80.30.7

Returns

USPHSEMCONEHABPNTGMedian
NameUS Physi.Select M.Concentr.Enhabit Pennant  
1M Rtn6.9%3.0%11.7%14.4%1.9%6.9%
3M Rtn-4.0%7.8%6.5%22.2%20.1%7.8%
6M Rtn15.2%5.0%9.7%55.2%29.0%15.2%
12M Rtn-2.2%-19.3%-0.2%34.4%7.5%-0.2%
3Y Rtn-3.1%2.9%-0.7%-30.1%148.6%-0.7%
1M Excs Rtn7.8%0.5%10.6%9.7%0.7%7.8%
3M Excs Rtn-5.5%9.6%7.3%25.8%22.9%9.6%
6M Excs Rtn7.0%-1.5%2.9%49.9%24.6%7.0%
12M Excs Rtn-15.2%-32.9%-9.4%19.8%-5.4%-9.4%
3Y Excs Rtn-70.1%-69.2%-72.7%-92.5%98.6%-70.1%

Financials

Segment Financials

Assets by Segment
$ Mil20242023202220212020
Physical therapy operations846709724500518
Industrial injury prevention services151149269443
Total997858749594561


Price Behavior

Price Behavior
Market Price$86.01 
Market Cap ($ Bil)1.3 
First Trading Date05/29/1992 
Distance from 52W High-7.1% 
   50 Days200 Days
DMA Price$77.80$78.20
DMA Trendupdown
Distance from DMA10.6%10.0%
 3M1YR
Volatility41.5%35.7%
Downside Capture145.2078.60
Upside Capture103.4465.30
Correlation (SPY)36.4%42.9%
USPH Betas & Captures as of 12/31/2025

 1M2M3M6M1Y3Y
Beta1.361.461.111.180.780.93
Up Beta1.981.571.061.750.851.10
Down Beta0.991.671.331.680.810.80
Up Capture212%95%72%61%47%51%
Bmk +ve Days11233772143431
Stock +ve Days13213567123384
Down Capture79%166%125%97%89%100%
Bmk -ve Days11182755108320
Stock -ve Days8192758126365

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USPH
USPH-0.6%35.7%0.04-
Sector ETF (XLV)14.5%17.4%0.6229.5%
Equity (SPY)15.8%19.3%0.6342.9%
Gold (GLD)79.5%20.4%2.786.3%
Commodities (DBC)5.7%15.3%0.1611.9%
Real Estate (VNQ)5.8%16.7%0.1738.1%
Bitcoin (BTCUSD)-14.7%39.8%-0.3119.5%


Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USPH
USPH-6.2%36.7%-0.08-
Sector ETF (XLV)7.9%14.5%0.3630.7%
Equity (SPY)14.0%17.1%0.6639.0%
Gold (GLD)20.8%15.7%1.078.0%
Commodities (DBC)11.4%18.7%0.4911.5%
Real Estate (VNQ)5.7%18.8%0.2135.0%
Bitcoin (BTCUSD)19.0%58.0%0.5316.4%


Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USPH
USPH7.0%39.2%0.30-
Sector ETF (XLV)10.6%16.6%0.5340.7%
Equity (SPY)15.3%18.0%0.7348.4%
Gold (GLD)15.7%14.9%0.874.7%
Commodities (DBC)8.2%17.6%0.3819.7%
Real Estate (VNQ)5.8%20.8%0.2547.6%
Bitcoin (BTCUSD)70.3%66.7%1.0914.9%


Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date12312025
Short Interest: Shares Quantity0.8 Mil
Short Interest: % Change Since 121520251.7%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest5.3 days
Basic Shares Quantity15.2 Mil
Short % of Basic Shares5.1%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-4.8%-7.6%-1.1%
8/7/202515.2%21.8%18.4%
5/7/2025-0.1%8.9%9.5%
2/28/20246.4%5.1%13.5%
11/8/2023-2.7%5.7%8.8%
8/9/2023-9.2%-12.5%-20.0%
5/5/20230.2%-2.9%-4.6%
2/23/20230.8%2.7%-6.9%
...
SUMMARY STATS   
# Positive8911
# Negative12119
Median Positive2.3%5.1%7.1%
Median Negative-3.4%-8.1%-20.0%
Max Positive15.2%28.2%29.2%
Max Negative-26.9%-29.4%-44.5%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202511/07/202510-Q (09/30/2025)
06/30/202508/08/202510-Q (06/30/2025)
03/31/202505/09/202510-Q (03/31/2025)
12/31/202403/03/202510-K (12/31/2024)
09/30/202411/08/202410-Q (09/30/2024)
06/30/202408/14/202410-Q (06/30/2024)
03/31/202405/08/202410-Q (03/31/2024)
12/31/202302/29/202410-K (12/31/2023)
09/30/202311/08/202310-Q (09/30/2023)
06/30/202308/09/202310-Q (06/30/2023)
03/31/202305/05/202310-Q (03/31/2023)
12/31/202202/28/202310-K (12/31/2022)
09/30/202211/08/202210-Q (09/30/2022)
06/30/202208/08/202210-Q (06/30/2022)
03/31/202205/09/202210-Q (03/31/2022)
12/31/202103/01/202210-K (12/31/2021)

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Reeve, Graham DCOODirectSell1125202571.0174352,7601,472,747Form
2Gilmartin, Kathleen A DirectBuy1124202569.004,000276,0001,710,234Form
3Ham, Nancy DirectSell911202581.7160049,026162,930Form
4Williams, Eric JosephPresident and COODirectSell908202585.251,00085,2502,159,468Form
5Reading, Christopher JChairman of the Board and CEODirectSell905202583.532,000167,0609,529,771Form